Woodland International Research Group (WIRG) To Showcase Newly Opened Pediatric / Specialty Unit at ASCPT 2017

News provided by

Mar 02, 2017, 10:00 ET

WATCHUNG, N.J., March 2, 2017 /PRNewswire/ -- Woodland International Research Group (WIRG), a subsidiary of Evolution Research Group, LLC (ERG), recently opened its new purpose-built, 16-bed clinical research unit (CRU) adjacent to its current 40-bed CRU. The new unit is designed specifically for child and adolescent inpatient trials in special populations including those suffering from CNS disorders and diseases in other therapeutic areas. Replacing the former dedicated "pediatric wing" of larger unit, the facility features bedside gaming, air hockey, crafts and other activities as well as a secure "fresh air" outdoor area. WIRG's well-established patient retention program includes education and tutoring for school-aged study participants.

This customized facility was designed for the comfort of patients and family members with two beds per room, allowing caregivers to stay overnight. It is also equipped with separate exam and procedure rooms. The staff consists of a board-certified child and adolescent psychiatrist, a board-certified family practitioner, also boarded in pain and addiction, RNs, LPNs, PCTs, nutritionists, CRCs, neuropsychiatric raters, phlebotomists, as well as regulatory, QC and ACLS certified staff. Recent pediatric phase 1-3 inpatient studies performed at WIRG have included trials in schizophrenia, bipolar disorder, ADHD, depression and GERD.

When not housing pediatric populations, the unit is also being utilized for WIRG's more complex trials in adult and elderly subjects. These studies include early phase Proof-of-Concept, Proof-of-Mechanism studies requiring smaller cohorts, serial PK sampling, PSG, EEG/qEEG, actigraphy, CSF sampling, intensive cardiac monitoring (QTc/TQT), and other specialized procedures.

Lori Wright, Chief Executive Officer of ERG is enthusiastic about the expanded capabilities stating, "Studies in pediatric populations have become increasingly demanded by the industry. We consulted on the design of the facility with several of our long-time clients who expressed a strong desire for access to a purpose-built pediatric unit independent of a hospital or academic institution." Commenting on the team in Little Rock, Ms. Wright added "I could not be prouder of the team that worked so diligently and carefully to ensure that comfort and safety was paramount in the design and execution of the build-out. While studies in infants, children and adolescents come with a unique set of demands and concerns, our team is highly experienced in working with these subjects and their families and have a proven track record of success."

ERG will be showcasing the expanded pediatric capabilities at the WIRG unit, along with its other unique early development services, at the 2017 American Society for Clinical Pharmacology and Therapeutics Annual Meeting being held March 15-18^th, 2017, in Washington, D.C. Visit ERG at Booth #50 to learn more or visit www.joinaresearchstudy.com.

About Evolution Research Group

Evolution Research Group, LLC is a clinical research site organization comprised of seven fully owned and operated clinical research units, an affiliate network of 11 clinical sites and its consulting arm, Thievon-Wright Consulting Group, LLC (TWCG). With access to over 400 beds and KOLs in several therapeutic specialties, ERG is frequently the first call made by industry teams planning early or late phase, complex inpatient and outpatient trials in psychiatry, neurology, addiction, sleep disorder, renal insufficiency, hepatic impairment, acute and chronic pain, among others. Thievon-Wright Consulting Group (TWCG) offers consulting services to pharmaceutical and CRO clients, including access to our key opinion leaders in Schizophrenia, Pain, Alzheimer's disease, Sleep Disorders, Depression, Hepatic/Renal Impairment, and Clinical Pharmacology. In addition, TWCG also offers general consulting in study design, protocol review and budget planning, vendor resources, study feasibility and site recommendations.

Jeanine M. Estrada, MBA
Media Relations
Evolution Research Group
Tel: (908) 280-8128
[email protected]
www.evolutionresearchgroup.com

SOURCE Evolution Research Group, LLC